Jefferies Group's NTLA Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 1,000 shares of Intellia Therapeutics, Inc. (NTLA) worth $12,820, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in NTLA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 1,000 shares. Largest reduction occurred in Q3 2024, reducing 700 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Intellia Therapeutics (NTLA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Intellia Therapeutics (NTLA) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,000 | New Buy | 1,000 | $12.82 |
| Q3 2024 | -700 | Sold Out | 0 | $0.00 |
| Q2 2024 | +700 | New Buy | 700 | $22.38 |
Jefferies Group's Intellia Therapeutics Investment FAQs
Jefferies Group first purchased Intellia Therapeutics, Inc. (NTLA) in Q2 2024, acquiring 700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Intellia Therapeutics, Inc. (NTLA) for 3 quarters since Q2 2024.
Jefferies Group's largest addition to Intellia Therapeutics, Inc. (NTLA) was in Q1 2026, adding 1,000 shares worth $12,820.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 1,000 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $12,820.
As of the Q1 2026 filing, Intellia Therapeutics, Inc. (NTLA) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Intellia Therapeutics, Inc. (NTLA) was 1,000 shares, as reported at the end of Q1 2026.